Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07214896

Deployment and Evaluation of Humanoid Robotics in Coalition-Aligned Clinical Care Settings

This clinical trial evaluates the deployment of humanoid robotics in coalition-aligned healthcare settings. The study measures biometric performance, ESG compliance, and operational impact across patient care, sanitation, and intake workflows. Humanoid units are enhanced via biotech integration and compensated through blockchain-based wage tokens. Outcomes will inform coalition governance, wage calibration, and metro-scale deployment strategies.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Mobility Impairment Clinical Workflow Optimization ESG-linked Healthcare Robotics Deployment Sanitation Protocol Compliance

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

ESG Compliance Lab, Frankfurt, Germany

Loading trial locations.

About this study

The HEALTH trial (Humanoid Evaluation and Learning Trial in Healthcare) is a coalition-aligned clinical study designed to assess the deployment of humanoid robotics in real-world care environments. Conducted across metro facilities in New York, Austin, Frankfurt, and Tokyo, the trial evaluates robotic performance in patient intake, sanitation, mobility assistance, and ESG-linked operations.

Humanoid units are enhanced through biotech integration, including skin cell regeneration dips and stem cell neural augmentation. Each unit is tracked via biometric audit scoring across five dimensions: motor function, cognitive response, ESG compliance, biotech retention, and human interaction. Scores are notarized via SHA-256 and published to the coalition dashboard.

Wage tokens (HumanoidWage, HMW) are minted based on performance thresholds and distributed through smart contracts to deployed units. FX arbitrage across Tokyo and Frankfurt informs reinvestment logic and 1031 exchange-backed yield farming pools. DAO voting governs deployment, wage calibration, and protocol expansion.

This trial aims to establish scalable, transparent frameworks for humanoid integration in healthcare, anchored in coalition governance, public oversight, and metro-ready infrastructure.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-75 years

Able to provide informed consent

Facility staff, clinical auditors, ESG observers, or coalition stakeholders

Willing to interact with humanoid robotics in clinical workflows

Available for biometric feedback and observational logging over 90 days

Exclusion criteria

  • Cognitive impairment preventing informed consent

Active infectious disease requiring isolation

Prior adverse reaction to biotech-enhanced robotics

Involvement in conflicting clinical trials

Inability to comply with protocol procedures or coalition transparency requirements

Treatment and study plan

Skin Cell Dip

Biological

Lab-grown keratinocyte dip applied to humanoid units to improve tactile sensitivity and surface regeneration.

Stem Cell Dip

Biological

iPSC-derived neuroblast dip applied to humanoid units to enhance neural responsiveness and adaptive learning.

Wage Token Distribution

Other

HumanoidWage (HMW) tokens minted and distributed based on biometric audit scores and ESG task completion.

Other names: Blockchain-based compensation

ESG Compliance Monitoring, Operational protocol

Behavioral

Real-time tracking of energy usage, sanitation cycles, and carbon offset metrics via coalition dashboard.

Primary outcomes

  1. Biometric Audit Score ≥85 Across Five Performance Dimensions

    Time frame: Measured at Day 30 Post-Deployment

    This outcome assesses the performance of humanoid robotics units deployed in coalition-aligned healthcare settings. Each unit is scored across five biometric dimensions: motor function, cognitive response, ESG compliance, biotech integration, and human interaction. Scores are notarized via SHA-256 and published to the coalition dashboard. Units achieving a composite score ≥85 are eligible for wage token bonuses, dip protocol expansion, and DAO-backed facility scaling.

Secondary outcomes

  1. ESG Audit Compliance Score ≥90

    Time frame: Humanoid units are evaluated for ESG-linked performance including energy usage, sanitation protocol adherence, and carbon offset metrics. Scores are published to the coalition dashboard and notarized via SHA-256. Units scoring ≥90 contribute to DAO-backe

    Measured at Day 60 Post-Deployment

  2. Wage Token Distribution Volume per Unit

    Time frame: Continuous Monitoring Over 90 Days

    Tracks the volume of HumanoidWage (HMW) tokens minted and distributed to each humanoid unit based on biometric audit scores and task completion. Token flow is logged on-chain and used to calibrate coalition wage pools and reinvestment logic.

  3. Clinical Workflow Efficiency Increase ≥15%

    Time frame: Measured at Day 90 Post-Deployment

    Assesses improvements in patient intake speed, sanitation cycle time, and mobility assistance throughput across facilities. Benchmarked against pre-deployment baselines and validated by coalition auditors.

Sponsors and collaborators

Lead sponsor

Truway Health, Inc.

Industry

Registry information

Official study title

HEALTH: Humanoid Evaluation and Learning Trial in Coalition-Aligned Healthcare Settings

Acronym: HEALTH

Important dates

Study start
2025
Primary completion
2031
Study completion
2031
First posted
Oct 9, 2025
Registry last updated
Oct 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.